MedPath

APO-NAPROXEN

APO-NAPROXEN

Approved
DIN Number

00522651

Drug Class

Human

Market Date

Dec 31, 1982

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00522651
AIG Number0109634001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AE02 NAPROXEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

NAPROXENActive
Strength: 250 MG
Monograph: NAPROXEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.